Re: Resverlogix Announces Apabetalone Meets Primary Endpoint in a Pulmonary Arterial Hypertension Pilot Study

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

10-41

Rank: President [?]

Points: 1511 [?]

Votes: 12 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix Announces Apabetalone Meets Primary Endpoint in a Pulmonary Arterial Hypertension Pilot Study

in response to

Re: Resverlogix Announces Apabetalone Meets Primary Endpoint in a Pulmonary Arterial Hypertension Pilot Study

Temsamany

posted on Sep 08, 2021 07:24PM

I thought it was - FINALLY - some positive news from a clinical trial!

They leaked it a bit earlier though, as this has been here:

https://clinicaltrials.gov/ct2/show/NCT04915300?spons=resverlogix&draw=2&rank=12

But, being what it is, the stock is down on the day! Zero marks on that end for not bringing in more buying, as it again fosters the appearance of a ho-hum news release. I don't think they get it!

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply